GLSHQ (Gelesis Holdings) ROE % Adjusted to Book Value: 0.00% (As of Jun. 2023)


What is Gelesis Holdings ROE % Adjusted to Book Value?

Gelesis Holdings GLSHQ -99.00% ROE % Adjusted to Book Value is 0.00% as of Jun. 2023.

Gelesis Holdings's ROE % for the quarter that ended in Jun. 2023 was 0.00%. Gelesis Holdings's PB Ratio for the quarter that ended in Jun. 2023 was N/A. Gelesis Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was N/A.

Gelesis Holdings ROE % Adjusted to Book Value Related Terms

Gelesis Holdings ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings ROE % Adjusted to Book Value Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
ROE % Adjusted to Book Value
0.00 0.00

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.07 0.00 0.00 0.00 0.00

GLSHQ vs RBSH, PPCB, RGMP: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Gelesis Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gelesis Holdings ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gelesis Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Gelesis Holdings's ROE % Adjusted to Book Value falls into.


Gelesis Holdings ROE % Adjusted to Book Value Calculation

Gelesis Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Gelesis Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Gelesis Holdings (GLSHQ) has a ROE % Adjusted to Book Value of 0.00% as of Jun. 2023. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' ROE % Adjusted to Book Value too high?
Gelesis Holdings' current ROE % Adjusted to Book Value is 0.00%.
How does Gelesis Holdings' ROE % Adjusted to Book Value compare to RBSH and PPCB?
Gelesis Holdings' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current ROE % Adjusted to Book Value is 0.00% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.